Adynxx Inc. (ADYX) Stock Price & Overview

NASDAQ:ADYX

Current stock price

3.61
-2.33 (-39.23%)
At close:
3.65
+0.04 (+1.11%)
After Hours:

The current stock price of ADYX is 3.61 null. Today ADYX is down by -39.23%. In the past month the price decreased by -50.75%.

ADYX Key Statistics

1-Month Range3.53 - 7.7003
Current ADYX stock price positioned within its 1-month range.
Market Cap
3.011M
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
-38.93
Dividend Yield
N/A

ADYX Stock Performance

Today
-39.23%
1 Week
-22.20%
1 Month
-50.75%
3 Months
N/A
Longer-term
6 Months N/A
1 Year N/A
2 Years N/A
3 Years N/A
5 Years N/A
10 Years N/A

ADYX Stock Chart

Adynxx Inc. / ADYX Daily stock chart

ADYX Technical Analysis

ChartMill assigns a technical rating of 0 / 10 to ADYX.


Chartmill TA Rating
Chartmill Setup Rating
ADYX Full Technical Analysis Report

ADYX Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to ADYX. While ADYX seems to be doing ok healthwise, there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
ADYX Full Fundamental Analysis Report

ADYX Earnings

Next Earnings DateN/A
Last Earnings DateN/A
ADYX Earnings History

ADYX Forecast & Estimates


Analysts
Analysts60
Price TargetN/A
EPS Next Y93.65%
Revenue Next YearN/A
ADYX Forecast & Estimates

ADYX Financial Highlights

Over the last trailing twelve months ADYX reported a non-GAAP Earnings per Share(EPS) of -38.93. The EPS decreased by -43.44% compared to the year before.


Income Statements
Revenue(TTM)2.22M
Net Income(TTM)-8.42M
Industry RankSector Rank
PM (TTM) -379.83%
ROA -83.16%
ROE -113.96%
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%N/A
Sales Q2Q%N/A
EPS 1Y (TTM)-43.44%
Revenue 1Y (TTM)9.76%
ADYX financials

ADYX Ownership

Ownership
Inst Owners0.08%
Shares834.00K
FloatN/A
Ins Owners429.31%
Short Float %N/A
Short RatioN/A
ADYX Ownership

About ADYX

Company Profile

Adynxx Inc. is a clinical-stage biopharmaceutical company. It is focused on therapeutics for the treatment of pain and inflammatory diseases. Adynxx Inc., formerly known as Alliqua BioMedical Inc., is based in San Francisco, United States.

Company Info

Adynxx Inc.

2150 CABOT BLVD WEST SUITE B

LANGHORNE PA 19047

CEO: David Johnson

Phone: 215-702-8550

Adynxx Inc. / ADYX FAQ

What does ADYX do?

Adynxx Inc. is a clinical-stage biopharmaceutical company. It is focused on therapeutics for the treatment of pain and inflammatory diseases. Adynxx Inc., formerly known as Alliqua BioMedical Inc., is based in San Francisco, United States.


Can you provide the latest stock price for Adynxx Inc.?

The current stock price of ADYX is 3.61 null. The price decreased by -39.23% in the last trading session.


What is the dividend status of Adynxx Inc.?

ADYX does not pay a dividend.


What is the ChartMill technical and fundamental rating of ADYX stock?

ADYX has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


Can you provide the market cap for Adynxx Inc.?

Adynxx Inc. (ADYX) has a market capitalization of 3.01M null. This makes ADYX a Nano Cap stock.